Hepatitis C virus transmission dynamics in injection drug users

Research output: Contribution to journalArticle

Abstract

Hepatitis C virus (HCV) presents several challenges to the development of prevention programs. HCV infection is persistent in up to 80% of cases, and viremic individuals may transmit infection to others. With 65-90% of injection drug users anti-HCV positive, a large reservoir of infection exists in most drug-injector populations. Studying the genetic variability of HCV infections could permit researchers to reconstruct chains of viral transmission in IDUs. However, the relationship of HCV to HIV epidemiology remains unclear and may depend on whether the proportions of infectious persons in the population are similar for both viruses.

Original languageEnglish (US)
Pages (from-to)1197-1212
Number of pages16
JournalSubstance Use and Misuse
Volume33
Issue number5
StatePublished - 1998

Fingerprint

Drug Users
Hepacivirus
contagious disease
drug
Injections
Virus Diseases
Program Development
epidemiology
Infection
Population
Epidemiology
Research Personnel
HIV
Viruses
human being
Pharmaceutical Preparations

Keywords

  • Drug injection
  • Epidemiology
  • Hepatitis viruses
  • Molecular epidemiology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Medicine (miscellaneous)
  • Psychology(all)

Cite this

Hepatitis C virus transmission dynamics in injection drug users. / Hagan, Holly.

In: Substance Use and Misuse, Vol. 33, No. 5, 1998, p. 1197-1212.

Research output: Contribution to journalArticle

@article{623d96eadae8415cb1b35951d2ac161c,
title = "Hepatitis C virus transmission dynamics in injection drug users",
abstract = "Hepatitis C virus (HCV) presents several challenges to the development of prevention programs. HCV infection is persistent in up to 80{\%} of cases, and viremic individuals may transmit infection to others. With 65-90{\%} of injection drug users anti-HCV positive, a large reservoir of infection exists in most drug-injector populations. Studying the genetic variability of HCV infections could permit researchers to reconstruct chains of viral transmission in IDUs. However, the relationship of HCV to HIV epidemiology remains unclear and may depend on whether the proportions of infectious persons in the population are similar for both viruses.",
keywords = "Drug injection, Epidemiology, Hepatitis viruses, Molecular epidemiology",
author = "Holly Hagan",
year = "1998",
language = "English (US)",
volume = "33",
pages = "1197--1212",
journal = "Substance Use and Misuse",
issn = "1082-6084",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Hepatitis C virus transmission dynamics in injection drug users

AU - Hagan, Holly

PY - 1998

Y1 - 1998

N2 - Hepatitis C virus (HCV) presents several challenges to the development of prevention programs. HCV infection is persistent in up to 80% of cases, and viremic individuals may transmit infection to others. With 65-90% of injection drug users anti-HCV positive, a large reservoir of infection exists in most drug-injector populations. Studying the genetic variability of HCV infections could permit researchers to reconstruct chains of viral transmission in IDUs. However, the relationship of HCV to HIV epidemiology remains unclear and may depend on whether the proportions of infectious persons in the population are similar for both viruses.

AB - Hepatitis C virus (HCV) presents several challenges to the development of prevention programs. HCV infection is persistent in up to 80% of cases, and viremic individuals may transmit infection to others. With 65-90% of injection drug users anti-HCV positive, a large reservoir of infection exists in most drug-injector populations. Studying the genetic variability of HCV infections could permit researchers to reconstruct chains of viral transmission in IDUs. However, the relationship of HCV to HIV epidemiology remains unclear and may depend on whether the proportions of infectious persons in the population are similar for both viruses.

KW - Drug injection

KW - Epidemiology

KW - Hepatitis viruses

KW - Molecular epidemiology

UR - http://www.scopus.com/inward/record.url?scp=0031807856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031807856&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 1197

EP - 1212

JO - Substance Use and Misuse

JF - Substance Use and Misuse

SN - 1082-6084

IS - 5

ER -